Stockscreener 앱 받기
2.08
4.00%
0.08
전일 마감가:
$2.00
열려 있는:
$1.97
하루 거래량:
7.12M
Relative Volume:
0.75
시가총액:
$1.97B
수익:
$1.31M
순이익/손실:
$-597.65M
주가수익비율:
-2.1443
EPS:
-0.97
순현금흐름:
$-425.62M
1주 성능:
-2.35%
1개월 성능:
-17.13%
6개월 성능:
-16.47%
1년 성능:
-57.29%
1일 변동 폭
$1.95
$2.13
1주일 범위
$1.95
$2.22
52주 변동 폭
$1.83
$5.43
Immunitybio Inc Stock (IBRX) Company Profile
명칭
Immunitybio Inc
전화
(844) 696-5235
주소
3530 JOHN HOPKINS COURT, SAN DIEGO
IBRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.08 | 1.97B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | 개시 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | BTIG Research | Buy |
| 2023-05-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | 개시 | Jefferies | Buy |
Immunitybio Inc 주식(IBRX)의 최신 뉴스
Why ImmunityBio Inc. (26CA) stock is upgraded to buyCPI Data & Long-Term Growth Plans - newser.com
What dividend safety rating applies to ImmunityBio Inc. (26CA) stockRisk Management & Advanced Technical Signal Analysis - newser.com
Will ImmunityBio's (IBRX) Surging Revenue and Lower Net Loss Shift Its Investment Narrative? - simplywall.st
Why ImmunityBio Inc. (26CA) stock is a strong analyst pickWeekly Trade Analysis & High Accuracy Investment Entry Signals - newser.com
Can machine learning forecast ImmunityBio Inc. recoveryJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Why ImmunityBio Inc. (26CA) stock stays undervaluedJuly 2025 Outlook & Daily Entry Point Alerts - newser.com
Intraday pattern recognizer results for ImmunityBio Inc.Analyst Upgrade & Short-Term High Return Strategies - newser.com
How ImmunityBio Inc. (26CA) stock responds to bond marketMarket Rally & Expert-Curated Trade Recommendations - newser.com
D. Boral Capital Maintains ImmunityBio (IBRX) Buy Recommendation - Nasdaq
ImmunityBio (IBRX): Assessing Valuation After Q3 Revenue Surge and Narrowed Losses - Yahoo Finance
Is ImmunityBio Inc. (26CA) stock a buy before earnings resultsChart Signals & Capital Protection Trade Alerts - newser.com
ImmunityBio Inc. recovery potential after sell offGDP Growth & Fast Gain Stock Trading Tips - newser.com
How ImmunityBio's (IBRX) Revenue Surge and Narrowed Losses May Affect Investor Outlook - Yahoo Finance
New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations - Business Wire
ImmunityBio Reports Revenue Surge Amid Financial Challenges - TipRanks
Will Valiant Communications Limited Stock Benefit From Industry Trends in YEAREarnings Growth Projections & Free High Velocity Capital Growth - earlytimes.in
Will ImmunityBio Inc. (26CA) stock justify high valuationSell Signal & Verified Stock Trade Ideas - newser.com
Why retail investors favor ImmunityBio Inc. stockQuarterly Investment Review & Community Trade Idea Sharing - newser.com
Will ImmunityBio Inc. stock continue upward momentumGap Down & Verified Momentum Stock Watchlist - newser.com
What moving averages say about ImmunityBio Inc.Quarterly Market Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How ImmunityBio Inc. (26CA) stock compares with tech leaders2025 Year in Review & Stock Portfolio Risk Control - newser.com
ImmunityBio Inc (26CA.BE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
ImmunityBio Inc. (IBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Revenue per share of ImmunityBio Inc – HAM:26CA - TradingView
Is ImmunityBio Inc a good long term investmentTechnical Analysis Insights & Swing Trade Smarter With Data Insights - earlytimes.in
Immunitybio Inc (IBRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
0.07%
자본화:
|
볼륨(24시간):